Rare diseases
Investigational molecules
Locations
1 Lilly Corporate Center, 46285-0001, United States
Clinical research includes breast cancer, non-small cell lung cancer, prostate cancer, colorectal cancer, pancreatic cancer, ovarian cancer, urothelial carcinoma, thyroid cancer, and other solid tumours, with additional studies in glioma, neuroblastoma, and advanced hematologic malignancies.
Research activity also covers tumour subtypes linked to KRAS, RET, FGFR3, IDH1, and IDH2 alterations.
Eli Lilly & Co. runs clinical trials in conditions such as Obesity, Overweight, Type 2 diabetes mellitus, Colitis ulcerative, among others.
Clinical trials run by this sponsor – those enrolling participants first.
Study of Brenipatide (LY3537031) in Adults with Major Depressive Disorder to Evaluate Delay of Relapse Compared with Placebo
GermanyStudy of LY4268989 adipic acid in adults with moderately to severely active ulcerative colitis
CroatiaA Phase 2a Study of ly4005130 in Adults with Severe Alopecia Areata
The NetherlandsEfficacy and Safety of LY4005130 Compared with Placebo in Adults with Non‑Segmental Vitiligo
BelgiumA study of loxo-435, enfortumab vedotin, and pembrolizumab in adults with advanced or metastatic bladder cancer
CzechiaA Study of Brenipatide Compared to Placebo for Adults with Uncontrolled Moderate to Severe Asthma
FranceOrforglipron for stress urinary incontinence in women with obesity or overweight
CzechiaStudy on Eltrekibart and Mirikizumab for Adults with Moderate to Severe Ulcerative Colitis
BelgiumStudy on the Effectiveness and Safety of Orforglipron for Weight Management in Adolescents with Obesity or Overweight
ItalyStudy on Lebrikizumab for Adults with Chronic Rhinosinusitis and Nasal Polyps Using Intranasal Corticosteroids
BelgiumStudy of LY3537982, pembrolizumab, and a drug combination for patients with advanced non-small cell lung cancer and a KRAS G12C mutation
AustriaA Study of Baricitinib to Preserve Beta Cell Function in Children and Adults Newly Diagnosed With Type 1 Diabetes
BelgiumIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
